128 related articles for article (PubMed ID: 12825165)
1. Prophylactic and therapeutic efficacy of human intravenous immunoglobulin in treating West Nile virus infection in mice.
Ben-Nathan D; Lustig S; Tam G; Robinzon S; Segal S; Rager-Zisman B
J Infect Dis; 2003 Jul; 188(1):5-12. PubMed ID: 12825165
[TBL] [Abstract][Full Text] [Related]
2. The clinical response of West Nile virus neuroinvasive disease to intravenous immunoglobulin therapy.
Shimoni Z; Bin H; Bulvik S; Niven M; Hazzan R; Mendelson E; Froom P
Clin Pract; 2012 Jan; 2(1):e18. PubMed ID: 24765417
[TBL] [Abstract][Full Text] [Related]
3. The role for intravenous immunoglobulin in the treatment of West Nile virus encephalitis.
Haley M; Retter AS; Fowler D; Gea-Banacloche J; O'Grady NP
Clin Infect Dis; 2003 Sep; 37(6):e88-90. PubMed ID: 12955669
[TBL] [Abstract][Full Text] [Related]
4. Novel Intravenous Immunoglobulin Therapy for the Prevention and Treatment of Candida auris and Candida albicans Disseminated Candidiasis.
Xin H; Rosario-Colon JA; Eberle K
mSphere; 2023 Feb; 8(1):e0058422. PubMed ID: 36688668
[TBL] [Abstract][Full Text] [Related]
5. An Atypical Presentation of West Nile Virus With Successful Treatment After Plasma Exchange and Intravenous Immunoglobulin.
Malone K; Abraham R; Mccurdy G; Devarkondal V; Stevens CM
Cureus; 2022 Apr; 14(4):e24003. PubMed ID: 35547450
[TBL] [Abstract][Full Text] [Related]
6. Engineering the Single Domain Antibodies Targeting Receptor Binding Motifs Within the Domain III of West Nile Virus Envelope Glycoprotein.
Hruškovicová J; Bhide K; Petroušková P; Tkáčová Z; Mochnáčová E; Čurlík J; Bhide M; Kulkarni A
Front Microbiol; 2022; 13():801466. PubMed ID: 35432292
[TBL] [Abstract][Full Text] [Related]
7. Obesity Enhances Disease Severity in Female Mice Following West Nile Virus Infection.
Geerling E; Stone ET; Steffen TL; Hassert M; Brien JD; Pinto AK
Front Immunol; 2021; 12():739025. PubMed ID: 34531877
[TBL] [Abstract][Full Text] [Related]
8. Clinical Outcomes of Japanese Encephalitis after Combination Treatment of Immunoglobulin, Ribavirin, and Interferon-α2b.
Son H; Sunwoo JS; Lee SK; Chu K; Lee ST
J Clin Neurol; 2021 Jul; 17(3):428-434. PubMed ID: 34184451
[TBL] [Abstract][Full Text] [Related]
9. Pathogenicity and virulence of West Nile virus revisited eight decades after its first isolation.
Saiz JC; Martín-Acebes MA; Blázquez AB; Escribano-Romero E; Poderoso T; Jiménez de Oya N
Virulence; 2021 Dec; 12(1):1145-1173. PubMed ID: 33843445
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of intravenous immunoglobulins for the treatment of viral encephalitis: a systematic literature review.
Wagner JN; Leibetseder A; Troescher A; Panholzer J; von Oertzen TJ
J Neurol; 2022 Feb; 269(2):712-724. PubMed ID: 33675421
[TBL] [Abstract][Full Text] [Related]
11. Importance of immunoglobulin therapy for COVID-19 patients with lymphocytopenia.
Nabih HK
Bull Natl Res Cent; 2021; 45(1):46. PubMed ID: 33642851
[TBL] [Abstract][Full Text] [Related]
12. COVID-19: benefits and risks of passive immunotherapeutics.
Gupta A; Karki R; Dandu HR; Dhama K; Bhatt ML; Saxena SK
Hum Vaccin Immunother; 2020 Dec; 16(12):2963-2972. PubMed ID: 32962524
[TBL] [Abstract][Full Text] [Related]
13. Treatment Options for COVID-19: A Review.
Ali MJ; Hanif M; Haider MA; Ahmed MU; Sundas F; Hirani A; Khan IA; Anis K; Karim AH
Front Med (Lausanne); 2020; 7():480. PubMed ID: 32850922
[No Abstract] [Full Text] [Related]
14. What to expect from different drugs used in the treatment of COVID-19: A study on applications and in vivo and in vitro results.
Marcolino VA; Pimentel TC; Barão CE
Eur J Pharmacol; 2020 Nov; 887():173467. PubMed ID: 32777212
[TBL] [Abstract][Full Text] [Related]
15. The anti-viral facet of anti-rheumatic drugs: Lessons from COVID-19.
Perricone C; Triggianese P; Bartoloni E; Cafaro G; Bonifacio AF; Bursi R; Perricone R; Gerli R
J Autoimmun; 2020 Jul; 111():102468. PubMed ID: 32317220
[TBL] [Abstract][Full Text] [Related]
16. A Molecular Determinant of West Nile Virus Secretion and Morphology as a Target for Viral Attenuation.
Basset J; Burlaud-Gaillard J; Feher M; Roingeard P; Rey FA; Pardigon N
J Virol; 2020 Jun; 94(12):. PubMed ID: 32269117
[TBL] [Abstract][Full Text] [Related]
17. Could Intravenous Immunoglobulin Collected from Recovered Coronavirus Patients Protect against COVID-19 and Strengthen the Immune System of New Patients?
Jawhara S
Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32218340
[TBL] [Abstract][Full Text] [Related]
18. Lack of Efficacy of High-Titered Immunoglobulin in Patients with West Nile Virus Central Nervous System Disease.
Gnann JW; Agrawal A; Hart J; Buitrago M; Carson P; Hanfelt-Goade D; Tyler K; Spotkov J; Freifeld A; Moore T; Reyno J; Masur H; Jester P; Dale I; Li Y; Aban I; Lakeman FD; Whitley RJ;
Emerg Infect Dis; 2019 Nov; 25(11):2064-2073. PubMed ID: 31625835
[TBL] [Abstract][Full Text] [Related]
19. A Gorilla Adenovirus-Based Vaccine against Zika Virus Induces Durable Immunity and Confers Protection in Pregnancy.
Hassan AO; Dmitriev IP; Kashentseva EA; Zhao H; Brough DE; Fremont DH; Curiel DT; Diamond MS
Cell Rep; 2019 Sep; 28(10):2634-2646.e4. PubMed ID: 31484074
[TBL] [Abstract][Full Text] [Related]
20. Arenaviruses and West Nile Virus in solid organ transplant recipients: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice.
Anesi JA; Silveira FP;
Clin Transplant; 2019 Sep; 33(9):e13576. PubMed ID: 31022306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
